- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Caplin Point Laboratories Limited — Updates, 13-03-2026: Press Release
13-03-2026 | 12:03 pm
13-03-2026 | 12:03 pm
Caplin Steriles (subsidiary) secured USFDA final approval for Potassium Phosphates Injection. This generic targets a US market with annual sales of $57 million (~₹5.7 Cr), significantly expanding Caplin Point's product portfolio and market reach.
No comments yet. Be the first to comment!